2009
Hormonal Contraception and Metabolic Outcomes in Women With or at Risk for HIV Infection
Womack JA, Scherzer R, Cole SR, Fennie K, Williams AB, Grey M, Minkoff H, Anastos K, Cohen MH, Tien PC. Hormonal Contraception and Metabolic Outcomes in Women With or at Risk for HIV Infection. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2009, 52: 581-587. PMID: 19950431, PMCID: PMC2886798, DOI: 10.1097/qai.0b013e3181b9e5ee.Peer-Reviewed Original ResearchConceptsCombined Hormonal ContraceptionGreater HOMA-IRNon-HC usersHormonal contraceptionHOMA-IRLow HDLHIV infectionMetabolic outcomesDensity lipoproteinWomen's Interagency HIV StudyHomeostasis model assessment estimateDisorders of glucoseAdverse metabolic outcomesHigh-density lipoproteinLow-density lipoproteinUninfected womenAntiretroviral therapyHigher HDLAdverse outcomesInsulin resistanceContraceptive efficacyHIV StudyReproductive ageCardiovascular diseaseHIV
2005
Use of Electronic Monitoring Devices to Measure Antiretroviral Adherence: Practical Considerations
Bova CA, Fennie KP, Knafl GJ, Dieckhaus KD, Watrous E, Williams AB. Use of Electronic Monitoring Devices to Measure Antiretroviral Adherence: Practical Considerations. AIDS And Behavior 2005, 9: 103-110. PMID: 15812617, DOI: 10.1007/s10461-005-1685-0.Peer-Reviewed Original Research